Thursday 26 May 2022
weather_iconWhite circle red arrow
SIGN UP
UAE
Courts
Government
Education
Heritage
Health
Transport
Science
Environment
Megaprojects
Expo 2020
UAE in Space
Gulf
Saudi Arabia
Bahrain
Oman
MENA
Egypt
Iraq
Iran
Jordan
Lebanon
Syria
Tunisia
Captagon Crisis
World
UK
US
Africa
Asia
Australasia
Europe
The Americas
Arab Showcase
Business
Aviation
Economy
Energy
Money
Cryptocurrencies
Property
Banking
Technology
Markets
Travel and Tourism
Start-Ups
Road to Net Zero
Future
Comment
Opinion
Comment
Editorial
Obituaries
Cartoon
Feedback
Lifestyle
Fashion
Food
Motoring
Luxury
Family
Home
Wellbeing
Things to do
Comment
Arts & Culture
Art
Books
Film
Music
On Stage
Television
Comment
Travel
Hotels
News
Airlines
Destinations
Responsible Tourism
Covid-19 Travel
Health
Coronavirus
Sport
Football
Cricket
IPL
F1
UFC
Golf
Rugby
Horse Racing
Tennis
Other Sport
Podcasts
Trending Middle East
Beyond the Headlines
Post Covid-19 Recovery
Business Extra
Pocketful of Dirhams
My 2020
Recorded
Seera
Books of my life
Weekend
weather_iconWhite circle red arrow
SIGN UP
The Middle East.
Explained
weather_iconWhite circle red arrow
SIGN UP
UAE
Gulf
MENA
World
Business
Opinion
Lifestyle
Arts & Culture
Travel
Health
Sport
Podcasts
Weekend
weather_iconWhite circle red arrow
SIGN UP
Astrazeneca
AstraZeneca swings to loss of £265m in 2021 despite bumper Covid vaccine sales
By
Alice Haine
●
February 10, 2022 at 4:25 am EST
AstraZeneca vaccine's reputation damage 'killed hundreds of thousands', says top scientist
By
Laura O'Callaghan
●
February 07, 2022 at 4:32 am EST
Oxford vaccine scientist says fourth Covid doses 'not sustainable' globally
By
Tim Stickings
●
January 04, 2022 at 5:39 am EST
Vaccine nationalism undermines pandemic response, AstraZeneca chairman says
By
Kelsey Warner
●
December 19, 2021 at 8:26 am EST
No, AstraZeneca can’t claim that T-cells trump antibodies in the fight against Covid-19
By
Jonathan Ball
●
November 23, 2021 at 3:22 pm EST
AstraZeneca’s Covid vaccine to turn profitable on new orders
By
Alice Haine
●
November 12, 2021 at 5:17 am EST
AstraZeneca vaccine developers play down Delta AY.4.2 fears
By
Laura O'Callaghan
●
October 20, 2021 at 7:48 am EDT
US to ease international travel ban on November 8
By
The National
●
October 15, 2021 at 11:33 am EDT
Johnson & Johnson files for booster authorisation with US FDA
By
The National
●
October 05, 2021 at 3:32 pm EDT
Covid-19 will become no worse than a common cold, AstraZeneca vaccine creator says
By
Nick Webster
●
September 23, 2021 at 2:21 am EDT
See more